Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-002617

President sold 30,000 shares at an average $56.10 ($1,682,877)

  • President acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-06 Exercise or conversion : show line 1 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-06 Sale : show line 2 in the form −14,192 $54.86 $778,573 808 D
2021-01-06 Sale : show line 3 in the form −808 $55.45 $44,804 0 D
2021-01-07 Exercise or conversion : show line 4 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-07 Sale : show line 5 in the form −15,000 $57.30 $859,500 0 D
Open-market sales · 30,000 sh · avg $56.10 · $1,682,877

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-01-06 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −15,000 335,000 D
2021-01-07 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −15,000 320,000 D
Loading xslF345X03/doc4.xml…